Trobix Bio
Trobix Bio
Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.
About
Technology stack
detected 2026-07-01No comments yet. Be the first to share your take.
What does Trobix Bio do?
Trobix Bio is developing orally administered precision oncology therapeutics by leveraging its TBX™ technology platform. This platform utilizes CRISPR, phage, and synthetic biology to precisely re-program specific bacterial activities within the human microbiome.
How much funding has Trobix Bio raised?
Trobix Bio has raised a total of $3M in funding. The most recent round on record is Series A.
Where is Trobix Bio headquartered?
Trobix Bio is headquartered in San Diego, United States.
When was Trobix Bio founded?
Trobix Bio was founded in 2019.
What industry does Trobix Bio operate in?
Trobix Bio operates in Life Sciences, Microbiome, Oncology, Therapeutics, Biotech, MedTech.
How many employees does Trobix Bio have?
Trobix Bio has approximately 13 people on record.
What is Trobix Bio's revenue?
StartupHub estimates Trobix Bio's annual revenue at $2.3M (range $1.2M to $3.5M, 64% confidence), based on comparable companies in the sector.
What is Trobix Bio's valuation?
StartupHub estimates Trobix Bio's effective valuation at $12.3M (range $7.5M to $18.0M, 10% confidence), based on comparable companies in the sector.